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Abstract
Exercise may activate a brown adipose-like phenotype in whiteBackground: 
adipose tissue. The aim of this systematic review was to identify the effects of
physical activity on the link between peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC-1a) and fibronectin type III
domain-containing protein 5 (FNDC5) in muscle, circulating Irisin and
uncoupling protein one (UCP1) of white adipocytes in humans.  TwoMethods: 
databases (PubMed 1966 to 08/2016 and EMBASE 1974 to 08/2016) were
searched using an appropriate algorithm. We included articles that examined
physical activity and/or exercise in humans that met the following criteria: a)
PGC-1a in conjunction with FNDC5 measurements, and b) FNDC5 and/or
circulating Irisin and/or UCP1 levels in white adipocytes.  We includedResults: 
51 studies (12 randomised controlled trials) with 2474 participants. Out of the
51 studies, 16 examined PGC-1a and FNDC5 in response to exercise, and only
four found increases in both PGC-1a and FNDC5 mRNA and one showed
increased FNDC5 mRNA. In total, 22 out of 45 studies that examined
circulating Irisin in response to exercise showed increased concentrations
when ELISA techniques were used; two studies also revealed increased Irisin
levels measured via mass spectrometry. Three studies showed a positive
association of circulating Irisin with physical activity levels. One study found no
exercise effects on UCP1 mRNA in white adipocytes.   TheConclusions:
effects of physical activity on the link between PGC-1a, FNDC5 mRNA in
muscle and UCP1 in white human adipocytes has attracted little scientific
attention. Current methods for Irisin identification lack precision and, therefore,
the existing evidence does not allow for conclusions to be made regarding Irisin
responses to physical activity. We found a contrast between standardised
review methods and accuracy of the measurements used. This should be
considered in future systematic reviews.
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Introduction
Brown adipose-like phenotype in white adipose tissue (WAT) 
may play a role in reducing body weight, and consequently lessen 
obesity in mammals1. Recently, acute and chronic exercise has 
been found to induce a brown adipose-like phenotype in WAT2 
through a number of sequential steps. Exercise is also known 
to increase the activation of the peroxisome proliferator- 
activated receptor gamma coactivator 1-alpha (PGC-1α) gene in 
human skeletal muscle3. PGC-1α is a co-transcriptional regulator 
facilitating multiple transcription factors to regulate a complex 
network of genes4 and it has been implicated in both the control 
of tissue mitochondrial content and the program that results in 
brown adipose tissue (BAT) formation5.
While skeletal muscle properly adapts to exercise in the absence 
of PGC-1α6, activation of PGC-1α was proposed to increase 
the fibronectin type III domain-containing protein 5 (FNDC5)2. 
FNDC5, is a membrane protein expressed in brain and skeletal 
muscle7. It was proposed that FNDC5 was cleaved during exercise, 
and released into the bloodstream as Irisin – a peptide fragment 
of FNDC5 measured by western blotting2. In vitro, exposure of 
white adipocytes to Irisin– through an unknown receptor – subse-
quently led to an increase of the peroxisome proliferator-activated 
receptor alpha, which in turn increased uncoupling protein one 
(UCP1) mRNA2. The increase in white adipocyte UCP1 mRNA 
observed with Irisin treatment, presented as fold-change over 
control, is hard to interpret since white adipocytes in culture do not 
usually express UCP1 mRNA8.
Since, UCP1 is the only contributor to non-shivering thermo-
genesis that occurs in BAT9 and it appears that the presence of 
UCP1 in a white adipocyte is accompanied by “brown-adipocyte 
like” properties8,10,11, it was proposed that increased circulating 
Irisin in humans after a chronic exercise program may promote 
increased weight loss and improved metabolic control through 
induction of UCP12. This hypothesis seemed superficially plau-
sible, as Irisin over-expression stimulated oxygen consumption 
and has been described to have an inverse association with blood 
glucose, insulin, total cholesterol and a positive association with 
adiponectin concentrations12. However, other studies have failed 
to observe such positive associations13–15, while the effect of 
exercise on “browning” of the white adipose phenotype remains 
unclear16–18.
The exact role of exercise in regulating circulating Irisin concen-
tration remains to be established. Indeed, data indicate that while 
older adults appear to have a 30% increase in FNDC5 mRNA in 
muscle compared to younger adults, FNDC5 mRNA was unrespon-
sive to six weeks of endurance training19, despite robust increases 
in mitochondria20. In general, results on the effects of exercise on 
circulating Irisin17,21–24 have been rather ambiguous; diverse meth-
odology may explain the highly discrepant results25,26. Given that 
Irisin continues to be measured using a variety of methods, an eval-
uation of the available evidence for its relationship with humans’ 
health is warranted, due to the potential that the browning of white 
adipocytes may have on human health. In addition, the proposed 
exercise mechanism that may cause a browning process of WAT in 
humans must be evaluated. Therefore, the aim of the current review 
was to systematically identify the effects of physical activity on 
the link between PGC-1α and FNDC5 in muscle, and circulat-
ing Irisin, as well as evidence for regulation of UCP1 in WAT 
(indicating a browning process) in humans.
Methods
Search strategy
Using the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines27–29, two databases 
(PubMed and EMBASE) were searched up until 19th August 
2016. Two investigators (PCD and IML) independently conducted 
two identical searches in both databases using appropriate 
search algorithms (PubMed: Supplementary File 1; EMBASE: 
Supplementary File 2). The lists of the included articles were 
reviewed to identify publications that were relevant to the topic 
under review.
Selection criteria
We included studies that met at least one of the following eligi-
bility criteria: a) measurements of PGC-1a (mRNA and/or protein 
concentrations) in conjunction with measurements of FNDC5; 
b) measurements of FNDC5, and/or Irisin concentrations and/or 
UCP1 in WAT, along with the following criteria: c) measure-
ments of physical activity levels and/or exercise interventions, and 
d) human participant study. No other eligibility criteria were set 
(e.g., language, date of publication). From the included studies, 
we retrieved outcomes regarding the effects of physical activity on 
PGC-1a in conjunction with FNDC5 in muscle, FNDC5 in muscle, 
Irisin in the bloodstream and UCP1 in WAT. We report the studies’ 
design, the participants’ characteristics, the Irisin identification and 
other outcome methods and study outcomes. We have also recorded 
the secondary associations in the included studies, i.e. associations 
between FNDC5 and/or circulating Irisin and several health-related 
phenotypes [e.g. energy expenditure, blood pressure, waist to hip 
ratio, body mass index (BMI)].
Risk of bias assessment and quality of reporting data
Two independent reviewers (PCD and GSM) evaluated the risk of 
bias of the studies included in the current review via the “Cochrane 
Collaboration’s tool for assessing risk of bias”30. Conflicts in the 
risk of bias assessment were resolved by IL and ADF. We also 
evaluated independently (PCD and GSM) the quality of report-
ing in the included randomised controlled trials (RCTs), con-
trolled trials (CTs) and single group design studies (SGS) using 
the Consolidated Standards of Reporting Trials (CONSORT) 
            Amendments from Version 1
We have implemented additional information regarding Irisin 
identification in content with the already existing argument in 
the text while we removed the detailed discussion of the most 
likely invalid ELISA. We have also included all the suggested 
information from the reviewers, regarding the differences 
that the existing studies displayed in the identification of the 
molecular weight of circulating Irisin. We removed repetition in 
the discussion section and redundancy in the results section. 
We have corrected minor errors in the Table 1 and the presented 
references in the text. As per the reviewers’ suggestions, we 
have included in the discussion two very important recent papers 
(Perakakis et al., 2017, Montes-Nieto et al., 2016). 
See referee reports
REVISED
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checklist31, which is a 25-item checklist and we provided a score 
for each study included. For CTs and SGS, we used a modified 
CONSORT checklist comprised of 18 items, given that these 
studies are not RCTs and therefore, seven out of the 25 items 
of the CONSORT checklist are not applicable for CTs and SGS 
(i.e. randomization, blinding). We also evaluated independently 
(PCD and GSM) the quality of the reporting data of the included 
cross sectional studies (CSS) using the 22-item checklist of 
the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) and we also provided a score for each 
study included32. Disagreements on studies’ CONSORT and 
STROBE scores were arbitrated by IL and ADF. JT and PS then 
reviewed the molecular and genomic content of the review inde-
pendent of the search process.
Results
The reporting of the available information in this systematic 
review is shown in a PRISMA checklist in Supplementary 
Table 1.
Searching procedure results
The initial searching date was the 14th September 2015 while 
weekly alerts were received from both databases up until the 
19th August 2016. Overall, the searching procedure revealed 
51 studies that involved 2474 participants and met the inclusion 
criteria, and were therefore included in this systematic review. The 
reference lists of these studies did not result in the identification of 
additional relevant articles. The searching outcome is presented 
in a PRISMA flow diagram in Supplementary Figure 1.
Characteristics of the included studies
The characteristics and the results of the included studies can be 
found in Table 1. From the 51 eligible studies, 12 (23.5%) were 
RCTs, of which four were cross-over RCTs, eight (15.7%) were 
CTs, 23 (45%) were SGS, and eight (15.7%) were CSS. One of 
the included RCTs33 reported the effect of resistance exercise 
training versus the effects of resistance exercise training com-
bined with Ursolic supplementation, because for the latter group 
the effects of resistance exercise cannot be isolated, we will 
report only the results from the resistance exercise training group. 
Furthermore, one of the CTs34 will be included in the results of 
both CTs and CSS because this study consisted of a controlled trial 
nested within a CSS. Eight of the included studies examined 
overweight/obese adults and children17,35–41, while 11 studies 
included a clinical population, including patients with chronic 
obstructive pulmonary disease (COPD)23,34,42, heart failure43, 
metabolic syndrome44, haemodialysis45, osteoporotic46, anorexia 
nervosa36,47, pre-diabetes16 and diabetes type II48.
Table 1. Characteristics of the studies included in the systematic review.
First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
PGG-1a and FNDC5 
Acute exercise 
Nygaard, 2015 C-RCT Two F and seven M 
moderately trained 
healthy
Aerobic exercise (2.1±0.8-fold over 
baseline, p=0.05) and resistance exercise 
(3.5±0.9-fold over baseline, p=0.01) 
increased PGC-1a splice 1 mRNA in 
muscle. No changes on FNDC5 mRNA in 
muscle. No correlations between PGC-1a 
splice variant 1 mRNA in muscle and Irisin.
NA NA
Norheim, 2014 CT 13 M healthy 
controls, and 11 M 
pre-diabetic
AE increased PGC-1a mRNA in muscle in 
both groups (7.4-fold over baseline).
NA NA
Pekkala, 2013 CT Healthy M: 17 
middle-age, 10 
young, 29 older
AE increased PGC-1a mRNA in muscle (4-
fold in young/2-fold in older over baseline). 
AE increased FNDC5 mRNA in muscle 
(1.4-fold over baseline, 95% CI=0.3-2.2) in 
young.
NA NA
Camera 2015 SGS Eight healthy 
trained M
AE increased PGC-1a mRNA in muscle 
4-hour post exercise (200%, p<0.05 over 
baseline and over control p<0.05), but it did 
not alter FNDC5 mRNA in muscle.
NA NA
Kurdiova, 2014 SGS Sedentary 
overweight/obese: 
10 M, Six F
AE increased PGC-1α mRNA in muscle 
(>6-fold over baseline), but it did not alter 
FNDC5 mRNA in muscle.
NA NA
Lecker, 2012 CSS 24 M systolic heart 
failure patients
PGC-1a mRNA was positively correlated 
with FNDC5 mRNA in muscle (r=0.56, 
p<0.05).
NA NA
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First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
Chronic exercise 
Norheim, 2014 CT 13 M healthy 
controls, and 11 M 
pre-diabetic
CE increased PGC-1a mRNA (1.2-fold 
in controls/1.6-fold in pre-diabetic over 
baseline) and FNDC5 mRNA (1.4-fold in 
controls/2-fold in pre-diabetic over baseline) 
in muscle. PGC-1a and FNDC5 mRNA in 
muscle was positively correlated (r=0.82, 
p<0.01) when data of both groups were 
combined.
NA NA
Pekkala, 2013 CT Healthy M: 17 
middle-age, 10 
young, 29 older
21 weeks of CE did not alter PGC-1a, 
FNDC5 mRNA in muscle.
NA NA
Timmons, 2012 CT 24 young sedentary 
and 43 healthy M
6 weeks of CE (intense cycling and 
resistance) did not alter FNDC5 mRNA in 
muscle.
FNDC5 mRNA in 
muscle was not 
linked to diabetes 
status.
NA
Alvehus, 2014 SGS 17 healthy young M 8 weeks of CE did not alter PGC-1a mRNA 
in both muscle and WAT and FNDC5 mRNA 
in muscle.
NA NA
Besse-Patin, 
2014
SGS 11 sedentary obese 
M
8 weeks of CE did not alter FNDC5 mRNA 
in muscle.
NA NA
Boström, 2012 SGS Eight non-diabetic 
M
10 weeks of CE increased FNDC5 mRNA in 
muscle (p<0.05)
NA NA
Ellefsen, 2014 SGS 18 untrained young 
F
12 weeks of CE decreased PGC-1a Slice4 
mRNA in muscle (p<0.05), but it did not 
alter FNDC5 mRNA in muscle.
NA NA
Huh, 2014 SGS Healthy: 78 M, 
15 M and 15 F 
adolescents
8 weeks of CE increased PGC-1a mRNA 
in muscle and FNDC5 mRNA in muscle 
(p<0.05).
NA NA
Kurdiova, 2014 SGS Sedentary 
overweight/obese: 
10 M, Six F
12 weeks of CE did not alter FNDC5 mRNA 
in muscle
NA NA
Raschke, 2013 SGS 13 healthy M A 10-week and 11-week program of CE did 
not alter FNDC5 mRNA in muscle.
The FNDC5 gene 
displays a non-ATG 
start codon and it 
was not activated by 
electrical stimulation.
NA
Scalzo, 2014 SGS Healthy: Seven M, 
12 F
3 weeks of CE did not alter FNDC5 mRNA 
in muscle
NA NA
IRISIN 
Acute exercise 
Nygaard, 2015 C-RCT Two F and seven M 
moderately trained 
healthy
Aerobic exercise (p=0.037) and resistance 
AE (p<0.001) increased Irisin. No 
correlations between Irisin and PGC-1a 
splice variant 1 mRNA in muscle.
NA PP, EK-067-29
Huh, 2015 C-RCT Eight healthy 
sedentary M, 4 M 
with MetS
AE (high density aerobic and resistance) 
increased Irisin in healthy and metabolic 
syndrome patients (p<0.05). Resistance 
exercise was more effective in increasing 
Irisin than endurance exercise.
NA PP, EK-067-52, 
and EK-067-29
Tsuchiya, 2014 C-RCT Six young healthy 
sedentary M
Low-intensity running increased Irisin 
(p<0.05) immediately after exercise 
compared with pre-exercise values.
NA PP, EK-067-52
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First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
Tsuchiya, 2015 C-RCT 10 healthy M Resistance AE increased Irisin (p<0.05) 
while endurance and combined (endurance 
+ resistance) AE did not alter Irisin.
Irisin was positively 
correlated with blood 
glucose (r=0.37, 
p<0.05), lactate 
(r=0.45, p<0.05) 
and plasma glycerol 
(r=0.45, p<0.05).
PP, EK-067-52
Norheim, 2014 CT 13 M healthy 
controls, and 11 M 
pre-diabetic
AE increased Irisin in both groups (1.2-fold 
over baseline). Irisin was not correlated 
with PGC-1a, FNDC5 mRNA in muscle and 
UCP1 mRNA in subcutaneous WAT.
NA PP, EK-067-52, 
and EK-067-29
Aydin, 2013 CT 14 obese M, and 14 
normal weight M
AE increased saliva Irisin (p<0.05). No 
changes in serum Irisin.
Serum Irisin was 
negatively correlated 
with BMI (r-0.944, 
p=0.005).
PP, EK-067-52
Kraemer, 2014 CT Healthy: Seven M, 
Five F
AE increased Irisin at 54th minute of 
the exercise session (20.4% compared 
to baseline, F(3,36)=5.28, p = 0.004), but 
decreased after the exercise session in M 
(p=0.021). AE increased Irisin at 54th minute 
(F(3,24)=5.03, p = 0.008) in F.
NA AB, 
Burlingame, 
CA, USA (CNS)
Huh, 2014 SGS Healthy: 78 M, 
15 M and 15 F 
adolescents
AE increased Irisin in treadmill (p<0.001) 
and swimming (p<0.05) conditions.
Irisin was positively 
correlated with 
blood lactate 
(r=0.30, p=0.04). 
Incubated Irisin 
in human skeletal 
muscle cells (in vitro) 
increased glucose 
and fatty acid uptake 
(p<0.05).
PP, EK-067-52
Moienneia, 
2016
SGS 21 sedentary young 
healthy F
AE of both low and high intensity resistance 
training did not alter Irisin (p>0.05).
NA ELISA 
CUSABIO, 
China
Anastasilakis, 
2014
SGS 20 young healthy 10 
F and 10 M
AE increased Irisin (p<0.001). No 
association of PA levels with circulating 
Irisin.
Irisin was positively 
correlated with LBM 
(r=0.28, p=0.02) and 
glucose (r=0.24, 
p=0.01) but it was 
not correlated with 
BMI, WHR, HOMA, 
insulin and leptin.
PP, EK-067-52
Comassi, 2015 SGS 14 M ironman 
racers, 13 M half-
ironman races
The half-ironman race increased Irisin 
(p<0.05).
NA Not mentioned
Daskalopoulou, 
2014
SGS Healthy: 22 M, 17 F AE (treadmill) increased Irisin (35% over 
baseline, p<0.001), with greater increase in 
maximal workload (p=0.004).
Irisin and lactate 
were positively 
correlated with their 
changes of pre-
post exercise after 
maximal workload 
(r=0.52, p=0.001).
Irisin was positively 
correlated with post 
exercise VO2max 
(r=0.39, p=0.02) 
but, not with post 
exercise REE.
PP, EK-067-52
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First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
Huh, 2012 SGS 15 healthy M AE increased Irisin (p=0.001) Irisin was not 
correlated with ATP 
levels after exercise
AB, Santa 
Clara, CA, USA 
(CNS)
Huh, 2014a SGS 14 healthy F AE (vibration) increased Irisin at both 
baseline (9%, p=0.05) and post CE (18%, 
p=0.05).
Irisin was positively 
correlated with 
cortisol after exercise 
(r=0.41, p=0.04).
PP, EK-067-52
Khodadadi, 
2014
SGS 21 overweight F High intense interval AE increased Irisin 
(33%, p=0.039). One session of Pilates 
exercise did not alter Irisin.
NA ELISA 
CUSABIO, 
China
Löffler 2015 SGS 28 healthy adults. 
Children 12 years 
and older, 48 M, 
40 F
AE increased Irisin in both adults (p=0.006) 
and children (p<0.001).
Irisin was positively 
associated with BMI 
(r=0.41, p=0.03), 
WHR (r=0.57, 
p=0.010, LBM 
(r=0.60, p=0.002), 
blood glucose 
(r=0.39, p=0.04) and 
triglycerides (r=0.44, 
p=0.02) as well as 
negatively with HDL 
(r=-0.46, p=0.01) in 
adults.
PP, EK-067-52
Lee, 2014 SGS Healthy: Six M, 
Four F
Submaximal AE increased Irisin (3.1-fold 
over baseline, p<0.05), whereas maximal 
AE did not alter Irisin following graded 
stepwise cold exposure.
Irisin increased after 
cold exposure and 
changes in Irisin 
concentrations 
positively correlated 
with shivering activity 
(r=0.91, p<0.001). 
REE was greater 
after maximal 
exercise compare to 
cold exposure.
Mass 
spectrometry/ 
Western blot 
BCA-kit/PP, 
Burlingame, 
CA, USA (CNS)
Chronic exercise 
Bang 2014 RCT Seven healthy 
Korean M
8 weeks of CE (resistance) did not alter 
Irisin.
Exercise did not alter 
blood glucose and 
insulin levels.
PP, 
Burlingame, 
CA, USA (CNS)
Greulich, 2014 RCT COPD patients: 26 
M, 14 F
8 days of a vibration exercise increased 
Irisin (p=0.01).
NA AB, INC. (CNS)
Greulich, 
2014a
RCT 22 F and 39 M 
COPD patients
Three months of CE did not alter Irisin in 
both non-individualized training group and 
individualized training group.
NA AB, INC. (CNS)
Hecksteden, 
2013
RCT Healthy sedentary: 
38 M, 64 F
No changes in Irisin after 26 weeks of 
aerobic exercise.
No relationship 
between changes in 
Irisin with age, sex 
and BMI.
AB, Santa 
Clara, CA, USA 
(CNS)
Kim 2015 RCT 40 elderly healthy F 12 weeks resistance CE increased Irisin 
compared to control group (p<0.05).
Irisin was positively 
correlated with 
muscle strength 
(r=0.526, p=0.002).
PP, USA
Kim, 2016 RCT 17 M and 11 F 
overweight and 
obese
8 weeks resistance CE increased Irisin 
compared to control group (p<0.05).
Irisin was positively 
associated with 
muscle mass 
(r=0.43, p=0.02) 
and negatively with 
fat mass (r=0.41, 
p=0.03)
PP, EK-067-16
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First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
Scharhag-
Rosenberger 
2014
RCT 37 exercised and 
34 controls healthy 
M and F
A 6-month resistance training program 
increased Irisin in control (p<0.01) but not 
in exercise group.
Resting metabolic 
rate was increased 
in exercise group 
(p<0.01) but was not 
associated with Irisin.
PP, 
Burlingame. 
CNS and 
Sunrise 
microplate 
reader (Tecan, 
Mannerdorf, 
Switzerland)
Tsuchiya, 2016 RCT 20 healthy M A 4-week sprint CE decreased Irisin 
(p<0.05).
NA PP, EK-067-52
Pekkala, 2013 CT Healthy M: 17 
middle-age, 10 
young, 29 older
21 weeks of CE did not alter Irisin Irisin and FNDC5 
mRNA in muscle 
were not associated 
with HOMA, plasma 
glucose and serum 
insulin.
PP, Inc., 
Burlingame, 
CA, USA 
(16–127)
Ijiri 2015a CT 8 M COPD patients 8 weeks of CE increased Irisin (p<0.05). AE 
did not alter Irisin.
Irisin was not 
correlated with 
pulmonary function 
parameters and 6-
min walk distance.
PP, 
Burlingame. 
(CNS)
Miyamoto-
Mikami 2015
CT 16 M and nine F 
young/ 12 M and 16 
F middle-aged older 
healthy
An 8-week CE program increased Irisin 
in middle-aged/older healthy (p<0.05). 
Exercise did not alter Irisin in young healthy 
individuals.
Irisin was negatively 
correlated with 
visceral adipose 
tissue after CE 
(r=0.54, p<0.05). 
No correlation of 
Irisin with abdominal 
subcutaneous 
adipose tissue area 
and whole-body fat.
PP, EK-067-16
Prestes, 2015 CT 72 elderly F 16 weeks of CE (resistance) did not 
increase Irisin.
NA MyBioSource 
Inc., San 
Diego, CA, 
USA (CNS)
Ellefsen, 2014 SGS 18 untrained young 
F
12 weeks of CE did not alter Irisin. Irisin was 
positively correlated with FNDC5 mRNA 
in muscle (r=0.65, 95% CI=0.12-0.89, 
p<0.05).
Irisin was not 
correlated with fat 
mass after exercise.
PP, EK-067-29
Kurdiova, 2014 SGS Sedentary 
overweight/obese: 
10 M, Six F
A 12-week CE did not alter Irisin. Irisin was negatively 
associated with 
fasting glycaemia 
(r=−0.52, p<0.05) 
but it was not 
associated with 
VO2max prior and 
post exercise.
PP, RK-067-16
Scalzo, 2014 SGS Healthy: Seven M, 
12 F
3 weeks of CE decreased Irisin in M 
(p<0.05) while it increased Irisin in F 
(p<0.001). Irisin was not correlated with 
FNDC5 mRNA.
Irisin was not 
correlated with 
fasting glucose, 
insulin and HOMA.
PP, 
Burlingame, 
CA, USA (CNS)
Moienneia, 
2016
SGS 21 sedentary young 
healthy F
An 8-week low intensity resistance training 
program did not alter Irisin. An 8-week high 
intensity resistance training reduced Irisin 
(p=0.034).
NA ELISA 
CUSABIO, 
China
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First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
Blüher, 2014 SGS 65 obese children 
7–18 years old M 
and F
12 months of PA intervention increased 
Irisin (12% over baseline, p=0.00003).
Irisin was not 
correlated with 
inflammatory markers 
at baseline.
PP, EK-067-52
Hew-Butler, 
2015
SGS Nine F non-runners A 10-week of walk/running program did not 
alter Irisin.
No relationship of 
Irisin with LBM, 
VO2peak and fat 
mass after the 
exercise program.
PP, 
Burlingame, 
CA (EK-067-52 
and EK-067-29)
Huh, 2012 SGS 15 healthy M 8 weeks of CE did not alter Irisin. NA AB, Santa 
Clara, CA 
(CNS)
Huh, 2014a SGS 14 healthy F 6 weeks of CE (vibration) did not change 
Irisin.
NA PP, EK-067-52
Löffler 2015 SGS 28 healthy adults. 
Children 12 years 
and older, 48 M, 
40 F
6 weeks in-house CE did not alter Irisin in 
children (n=62). Three years of low grade 
PA intervention in children did not alter 
Irisin.
NA PP, EK-067-52
Moraes, 2013 SGS 13 M, and 13 F 
haemodialysis 
patients
A 6-month CE program did not alter Irisin. Irisin was greater 
in haemodialysis 
patients than in 
healthy at baseline 
(p<0.05). No 
correlation with 
physical capacity, 
anthropometry and 
creatinine levels.
PP, 
Burlingame. 
(CNS)
Murawska-
Cialowicz, 
2015
SGS Seven M and five F 
healthy
A 3-month cross-fit training program 
increased Irisin only in F.
Irisin was positively 
correlated with BMI 
(r=0.48, p=0.02), 
fat mass % (r=0.56, 
p=0.014) and 
VO2max (r=0.43, 
p=0.012) only in M.
ELISA: 
BioVendor- 
Laboratorni 
Medicina, 
Czech 
Republic
Palacios-
González, 
2015
SGS 85 healthy children 
8–11 years old. 45 F 
and 40 M
An 8-month PA program did not alter Irisin 
levels.
Irisin was positively 
associated with 
BMI before (r=0.78, 
p<0.001) and after 
(r=0.82, p<0.001) 
the PA program as 
well as leptin (r=0.72, 
p<0.001) after the PA 
program.
Cusabio 
Biotech. (CNS)
Boström, 2012 SGS Eight non-diabetic 
M
10 weeks of CE increased Irisin (2-fold over 
baseline, p<0.05).
Irisin did not alter 
oxygen consumption 
and weight loss in 
vivo.
Western 
blot BCA-
kit (Thermo 
Scientific)
Al-Daghri, 
2015
CSS 35 M/48 F diabetes 
type 2 patients and 
42 M/39 F healthy
Habitual PA was positively associated with 
Irisin in healthy (r=0.20, p=0.03).
Irisin was positively 
correlated with 
waist circumference 
(r=0.23, p=0.04) 
in healthy and 
negatively with LBM 
(r=-0.26, p=0.02) 
and diastolic blood 
pressure (r=-0.25, 
p=0.02) in diabetes 
type II patients.
PP. (CNS)
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First author Design Participants Main outcome Secondary outcome
Method of 
circulating 
Irisin 
identification
Hofmann, 2014 CSS 39 anorexic F Irisin was not correlated with numbers of 
steps per day.
No relationship of 
Irisin, with METs, 
energy expenditure.
PP, RK-067-16
Ijiri 2015b CSS 65 M and seven 
F COPD patients. 
24 M and three F 
healthy controls
Physical activity levels were positively 
associated with Irisin in both COPD patients 
(r=0.83, p<0.01) and healthy controls 
(r=0.79, p<0.001).
NA PP, 
Burlingame. 
(CNS)
Kwaśniewska, 
2016
CSS 62 healthy M Irisin was positively correlated with physical 
activity levels in individuals demonstrated 
high weekly energy expenditure (2050–3840 
kcal/week) (p=0.04).
Irisin was inversely 
correlated with 
VO2peak (p<0.05).
ELISA 
BioVendor, 
Czech 
Republic
Moreno, 2015 CSS 191 M and 230 F 
non-diabetic
Irisin was higher in physically active 
(128.55±78.71 ng/ml) than in sedentary 
individuals (105.66±60.2) (p=0.006).
Irisin was positively 
associated with 
weight (r=0.13, 
p=0.008), BMI 
(r=0.15, p=0.002), 
triglycerides (r=0.17, 
p<0.0001), insulin 
(r=0.11, p=0.020) 
and HOMA (r=0.10, 
p=0.037) and 
negatively with HDL 
(r=-0.19, p=0.001).
AB INC, Santa 
Clara, CA, 
SK00170-01
Palermo 2015 CSS 65 postmenopausal 
F affected by 
osteoporosis
No correlation between circulating Irisin and 
daily PA.
No relationship 
between Irisin and 
LBM, fat mass, body 
mass density and 
METs.
AG-45A-
0046EK-KI01; 
Adipogen 
AG, Liestal, 
Switzerland
Pardo, 2014 CSS 30 anorexic, 66 
obese, 49 healthy F
Irisin was negatively correlated with daily PA 
(r=−0.22, p=0.001).
Irisin was positively 
correlated with REE 
(r=0.34, p=0.001), 
LBM (r=0.43, 
p=0.001), fat mass 
(r=0.52, p<0.001), 
glucose (r=0.22, 
p=0.0026), insulin 
(r=0.34, p<0.001), 
HOMA (r=0.33, 
p=0.001), BMI 
(r=0.52, p<0.001).
PP, EK-067-52
Jedrychowski 
2015
CSS Four sedentary 
controls M and Six 
young healthy M
Irisin was higher in exercisers (4.3 ng/ml) 
after a 12-week high-intensity aerobic CE 
compared to non-exercisers (3.6 ng/ml) 
(p=0.04).
NA Mass 
spectrometer 
(Thermo Fisher 
Scientific)
UCP1 
Chronic exercise 
Norheim, 2014 CT 13 M healthy 
controls, and 11 M 
pre-diabetic
CE increased UCP1 mRNA in subcutaneous 
WAT (1.82-fold over baseline, p<0.05) when 
data of both groups were combined
NA NA
C-RCT: cross-over randomized controlled trail; F: females; M: males; AE: Acute exercise; PGC-1α: peroxisome proliferator-activated receptor-γ coactivator 1α; 
FNDC5: Fibronectin type III domain-containing protein 5; PP: Phoenix Pharmaceuticals; NA: none available; CT: Controlled trial; CE: chronic exercise; UCP1: 
Uncoupling protein 1; WAT: White adipose tissue; CI: confidence interval; HOMA: homeostatic model assessment; CNS: Code not specified; SGS: Single group 
design studies; VO2max: Maximal oxygen uptake; CSS: Cross-sectional study; RCT: Randomized control trial; COPD: Chronic obstructive pulmonary disease; 
AB: Aviscera Bioscience; BMI: Body mass index; MetS: Metabolic Syndrome; LBM: Lean body mass; WHR: Waist to hip ratio; REE: Resting energy expenditure; 
VO2peak: peak oxygen uptake; WHR: waist to hip ratio; ATP: Adenosine triphosphate; PA: Physical activity; HDL: High density lipoprotein; METs: Metabolic 
equivalent.
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Risk of bias and quality of reporting data
The estimated risk of bias assessment results can be found in 
Table 2, and a summary is displayed in Supplementary Figure 2. 
Five RCTs44,49–52, and all the included CTs and CSS, as well as 22 
of the 23 SGS, displayed a high risk of bias due to inadequate gen-
eration of a randomised sequence, while four RCTs23,33,42,53 showed 
low risk of bias, and three RCTs41,54,55, as well as one SGS56, showed 
unclear risk of bias because there was no description of the method 
Table 2. Risk of bias assessment using the Cochrane 
Collaboration’s tool.
First author
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RCTs
Bang, 2014 + - - - + + +
Greulich, 2014 + + - + + + +
Greulich, 2014a + + - ? + + +
Hecksteden, 2013 + + - + + + +
Kim, 2015 - - - - + + +
Kim, 2016 ? - - - + + +
Scharhag-
Rosenberger, 2014 ? ? - + + + +
Huh, 2015 - ? - ? ? + +
Nygaard, 2015 - + - ? ? + +
Tsuchiya, 2014 - + - ? ? + +
Tsuchiya, 2015 - + - ? ? + +
Tsuchiya, 2016 ? - - - ? + +
CTs
Aydin, 2013 - - - - ? + +
Ijiri, 2015a - - - - ? + +
Kraemer, 2014 - - - - ? + +
Miyamoto-Mikami, 
2015 - - - - ? + +
Norheim, 2014 - - - ? ? + +
Pekkala, 2013 - - - - ? + +
Prestes, 2015 - - - - + + +
Timmons, 2012 - - - - ? + +
SGS
Alvehus, 2014 - - - - ? + +
Anastasilakis, 2014 - - - - ? + +
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Besse-Patin, 2014 - - - - ? + +
Blüher, 2014 - - - - + + +
Boström, 2012 - - - - ? + +
Camera, 2015 - - - - ? + +
Comassi, 2015 - - - - + + +
Daskalopoulou, 
2014 - - - - ? + +
Ellefsen, 2014 - - - - ? + +
Hew-Butler, 2015 - - - - + + +
Huh, 2012 - - - - ? + +
Huh, 2014 - - - - ? + +
Huh, 2014a - - - - ? + +
Khodadadi, 2014 - - - - ? + +
Kurdiova, 2014 - - - - ? + +
Lee, 2014 - - - - ? + +
Löffler, 2015 - - - - ? + +
Moraes, 2013 - - - - ? + +
Murawska-
Cialowicz, 2015 - - - - + + +
Moienneia, 2016 ? - - - + + +
Palacios-González, 
2015 - - - - ? + +
Raschke, 2013 - - - - ? + +
Scalzo, 2014 - - - - ? + +
CSS
Al-Daghri, 2015 - - - - ? + +
Hofmann, 2014 - - - - ? + +
Ijiri, 2015b - - - - ? + +
Jedrychowski, 2015 - - - - ? + +
Kwaśniewska, 2016 - - - - + + +
Lecker, 2012 - - - - ? + +
Moreno, 2015 - - - - ? + +
Palermo, 2015 - - - - ? + +
Pardo, 2014 - - - - ? + +
+: Low risk of bias; -: High risk of bias; ?: Unclear risk of bias; RCT: 
Randomised controlled trials; CT: Controlled trials; SGS: Single group design 
studies; CSS: Cross sectional studies.
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used for allocation (even though the participants were said to be 
“randomly” assigned). Six RCTs23,42,49,50,52,53 displayed low risk of 
bias for “allocation concealment”, while two44,54 showed unclear 
risk of bias because of the lack of description of the randomization 
allocation. Also, four RCTs33,41,51,55, and all the included CTs and 
SGS, as well as CSS, showed high risk of bias due to the lack of 
concealment of allocations before assignment. In “blinding of par-
ticipants and personnel”, all RCTs, CTs, SGS and CSS displayed 
high risk of bias because the exercise interventions could not be 
blinded to the participants.
In “blinding of outcome assessment”, three RCTs displayed low 
risk of bias23,53,54, while five RCTs42,44,49,50,52 and one CT16 showed 
unclear risk of bias because of the lack of information regarding 
the blinding of assessments. Also, four RCTs33,41,51,55, the remain-
ing seven CTs, and all the included SGS and CSS showed high 
risk of bias due to the knowledge of the allocated interventions 
by the assessors. Seven RCTs23,33,41,42,51,53,54, one CT37, five 
SGS39,56–59 and one CSS60 displayed low risk of bias, while five 
RCTs44,49,50,52,55, the remaining seven CTs, the remaining 18 SGS 
and the remaining eight CSS showed unclear risk of bias for 
“incomplete outcome data” because of the lack of information 
on the participants who dropped out or exclusions in the analysis. 
All the included studies showed low risk of bias of “selective 
reporting” because they reported all the outcomes measured, and 
all the included studies displayed low risk of bias in “other bias”.
The results of our evaluation in the quality of the reporting 
data showed a mean score of 13.6 out of 25 (54.4%) for the 
included RCTs, 10.56 out of 18 (58.68%) for the included CTs 
and 10.52 out of 18 (58.44%) for the included SGS (Table 3). 
The CSS displayed a mean score of 13.37 out of 22 (60.8%) 
(Table 4). The score represents the number of items (with 
percentage of items) on the checklist that were reported 
satisfactorily in each study. Therefore, a high score represents a 
high adherence to reporting guidelines, while a low score repre-
sents low adherence to reporting guidelines.
Reporting of the outcomes
The link between PGG-1a and FNDC5 in muscle in response to 
physical activity/exercise
Acute effects of exercise
Five studies16,17,50,61,62 investigating the link between PGC-1α 
with FNDC5 in muscle in response to acute exercise showed an 
increase of the PGC-1α mRNA in muscle; however, only two 
studies16,62 also found an increase in muscle FNDC5 mRNA, 
while one study43 detected a positive association of PGC-1α 
with FNDC5 in muscle. More specifically, a study found that an 
aerobic (2.1±0.8-fold over baseline, p=0.05) and a resistance 
(3.5±0.9-fold over baseline, p=0.01) training session increased 
PGC-1α splice variant1 but it did not change FNDC5 mRNA 
in the muscle of healthy adults50. Similarly, a resistance training 
session increased PGC-1α splice variant1 four hours post exer-
cise (200%, over baseline and over control, p<0.05), but it did 
not change FNDC5 mRNA in the muscle of healthy adults61. A 
45-minute endurance exercise session increased Exon 11 of 
PGC-1α mRNA in muscle (7.4-fold over baseline, p<0.05), but it 
did not change FNDC5 mRNA in muscle in both healthy and 
pre-diabetic adults, while a positive association between PGC-1α 
Table 3. Quality of the reporting of the results using the 
CONSORT checklist. Score represents the number of items 
(with percentage of items) on the checklist that were reported 
satisfactorily in each study. Therefore, a high score represents 
a high adherence to reporting guidelines, while a low score 
represents low adherence to reporting guidelines.
First author Design Score
1 Hecksteden, 2013 RCT (16.5/25) 66%
2 Bang, 2014 RCT (14.5/25) 58%
3 Greulich, 2014 RCT (18/25) 72%
4 Greulich, 2014a RCT (16.5/25) 66%
5 Scharhag-Rosenberger, 2014 RCT (15/25) 60%
6 Tsuchiya, 2014 RCT (10.5/25) 42%
7 Nygaard, 2015 RCT (11.5/25) 46%
8 Kim, 2015 RCT (14/25) 56%
9 Kim, 2016 RCT (14/25) 56%
10 Huh, 2015 RCT (12.5/25) 50%
11 Tsuchiya, 2015 RCT (12/25) 48%
12 Tsuchiya, 2016 RCT (8.5/25) 34%
13 Timmons, 2012 CT (6/18) 33%
14 Pekkala, 2013 CT (9/18) 50%
15 Aydin, 2013 CT (10.5/18) 58%
16 Norheim, 2014 CT (11/18) 61%
17 Kraemer, 2014 CT (10.5/18) 58%
18 Ijiri, 2015a CT (11.5/18) 64%
19 Miyamoto-Mikami, 2015 CT (11.5/18) 64%
20 Prestes, 2015 CT (14.5/18) 80%
21 Boström, 2012 SGS (7/18) 39%
22 Huh, 2012 SGS (10.5/18) 58%
23 Raschke, 2013 SGS (9/18) 50%
24 Moraes, 2013 SGS (12/18) 67%
25 Murawska-Cialowicz, 2015 SGS (9.5/18) 52.7%
26 Moienneia, 2016 SGS (9/18) 50%
27 Alvehus, 2014 SGS (10/18) 55%
28 Besse-Patin, 2014 SGS (13/18) 72%
29 Ellefsen, 2014 SGS (10/18) 55%
30 Huh, 2014 SGS (11/18) 61%
31 Kurdiova, 2014 SGS (11.5/18) 64%
32 Scalzo, 2014 SGS (11/18) 61%
33 Anastasilakis, 2014 SGS (11.5/18) 64%
34 Blüher, 2014 SGS (14/18) 80%
35 Daskalopoulou, 2014 SGS (12.5/18) 69%
36 Huh, 2014a SGS (6/18) 33%
37 Khodadadi, 2014 SGS (10.5/18) 58%
38 Lee, 2014 SGS (8.5/18) 47%
39 Camera, 2015 SGS (7/18) 39%
40 Comassi, 2015 SGS (13/18) 72%
41 Hew-Butler, 2015 SGS (12.5/18) 69%
42 Löffler, 2015 SGS (11/18) 61%
43 Palacios-González, 2015 SGS (12/18) 67%
CONSORT: Consolidated Standards of Reporting Trials; RCT: Randomized 
controlled trial; CT: Controlled trial; SGS: Single group design study.
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Table 4. Quality of the reporting of the results using 
the STROBE checklist. Score represents the number of 
items (with percentage of items) on the checklist that were 
reported satisfactorily in each study. Therefore, a high 
score represents a high adherence to reporting guidelines, 
while a low score represents low adherence to reporting 
guidelines.
First author Design Score
1 Lecker, 2012 CSS (13.3/22) 60.45 %
2 Pardo, 2014 CSS (12.2/22) 55.45 %
3 Hofmann, 2014 CSS (15.6/22) 70.9 %
4 Ijiri, 2015b CSS (13.5/22) 61.36%
5 Jedrychowski 2015 CSS (12/22) 54.45 %
6 Kwaśniewska, 2016 CSS (15/22) 68.1 %
7 Moreno, 2015 CSS (12.5/22) 56.81 %
8 Palermo, 2015 CSS (13.5/22) 61.36 %
9 Al-Daghri, 2015 CSS (12.8/22) 58.18 %
STROBE: Strengthening the Reporting of Observational Studies in 
Epidemiology; CSS: Cross-sectional study.
and FNDC5 mRNA was found at baseline (r=0.82, p<0.01) when 
data of the two groups were combined16. Furthermore, PGC-1α 
mRNA in muscle increased (>6-fold over baseline, p<0.05) in 
response to acute exercise; however, FNDC5 mRNA in muscle 
was not altered in sedentary overweight and obese adults17. Also, 
a resistance exercise session increased Exon 11 of PGC-1α mRNA 
in muscle of both young (4-fold over baseline, p<0.05) and older 
(2-fold over baseline, p<0.05) healthy adults, while it increased 
FNDC5 mRNA in muscle only in young (1.4-fold over baseline, 
95% Confidence Interval=0.3–2.2, p<0.05) healthy adults62. Finally, 
PGC-1α mRNA in muscle was positively associated with FNDC5 
mRNA in muscle (r=0.56, p<0.05) in a sub-set of 24 patients with 
heart failure43; stratification was ad hoc.
Chronic effects of exercise
Of the eleven eligible  studies2,16–19,40,62–67 that examined the link 
between PGC-1α with FNDC5 in muscle in response to chronic 
exercise, only two16,66 showed that chronic exercise increased 
PGC-1α and FNDC5 mRNA in muscle, while four studies18,19,62,63 
showed no effect of chronic exercise on PGC-1α and FNDC5 
mRNA in muscle. In the five studies that only measured FNDC5 
in muscle, one study2 found increased and four17,40,64,65 showed 
no effect of chronic exercise on FNDC5 mRNA in muscle.
A 12-week of endurance and resistance combined exercise train-
ing increased Exon 11 of PGC-1α mRNA in muscle (1.2-fold in 
healthy and 1.6-fold in pre-diabetic adults over baseline, p<0.05) 
and FNDC5 mRNA in muscle (1.4-fold in healthy and 2-fold in 
pre-diabetic adults over baseline, p<0.05)16. Furthermore, an 
8-week sprints exercise program increased PGC-1a and FNDC5 
mRNA in muscle (p<0.05) in healthy adults66. Finally, Bostrom 
et al. (2012) showed that in eight older participants selected from 
a larger group of 27 participants, chronic exercise increased 
FNDC5 mRNA in muscle (p<0.05)2.
A 21-week endurance and resistance combined exercise program in 
healthy adults did not alter PGC-1α and FNDC5 mRNA in muscle62. 
One of the included studies19 found no effect of chronic exercise 
on PGC1a or FNDC5 mRNA in younger adults (despite detecting 
significant changes in ~1,000 other mRNAs and finding mito-
chondrial enzyme activity was increased in ~25%)68. Similarly, an 
8-week resistance exercise program did not alter PGC-1α or 
FNDC5 mRNA in muscle of young healthy adults63. In addition, 
12 weeks of resistance training did not alter PGC-1α splice vari-
ant1 mRNA, and it did not change the FNDC5 mRNA in muscle 
in untrained young females18. Also, a 12-week aerobic and resist-
ance exercise combined program17 and an 8-week aerobic exercise 
program40 did not alter FNDC5 mRNA in muscle of sedentary 
obese adults, while chronic exercise had no effect on FNDC5 
mRNA in muscle of healthy adults64. Finally, a 3-week sprint 
interval training program did not alter FNDC5 mRNA in muscle 
of healthy adults65. 
The effects of physical activity/exercise on Irisin
Acute effects of exercise
Studies using enzyme-linked immunosorbent assays (ELISA)
Eighteen of the included studies12,17,21,22,34,35,38,44,49,50,52,56,58,62,66,69–71 
examined the effects of acute exercise on circulating Irisin, and 
a further seven studies34,36,46–48,60,72 investigated the association of 
circulating Irisin with physical activity levels using commercial 
ELISA kits. Thirteen studies12,21,22,38,44,49,50,52,58,66,69–71 showed that 
acute exercise increased circulating Irisin in healthy individuals, 
while five studies17,34,35,56,62 showed no effect of acute exercise on 
circulating Irisin. Also, three studies34,48,60 showed a positive associ-
ation of circulating Irisin with physical activity levels in healthy and 
COPD patients, while four studies36,46,47,72 showed no association or 
a negative association of circulating Irisin with physical activity 
levels in both healthy and clinical populations.
A resistance training session did not change FNDC5 mRNA in the 
muscle of healthy adults and circulating Irisin increased (p<0.001) 
over the following 24-hour50, indicating no short-term associa-
tion between FNDC5 and Irisin. Furthermore, an aerobic exercise 
session increased circulating Irisin (p=0.04) and Irisin concentra-
tions were measured at ~355–459 ng/ml50, greater than recent mass 
spectrometry measurements73. Similarly, a running exercise session 
in healthy individuals49 and an aerobic exercise session, as well as a 
resistance exercise session, in healthy individuals and in metabolic 
syndrome patients44 increased circulating Irisin (p<0.05). In the lat-
ter studies, Irisin concentrations measured at ~99–175 ng/ml49 and 
~80–94.6 ng/ml44, respectively, which is greater than recent mass 
spectrometry measurements73. Also, an acute resistance exercise 
session increased circulating Irisin (p<0.05) as oppose to aerobic 
and combined (aerobic and resistance) sessions that did not alter 
circulating Irisin in healthy males (Irisin concentrations ~18–151 
ng/ml)52. Furthermore, a 90-minute aerobic exercise session 
increased circulating Irisin during (54th minute) the exercise session 
(20.4% compared to baseline, F(3,36)=5.28, p=0.004), but circulating 
Irisin decreased after the exercise session (p=0.021) in healthy 
male adults69. In the latter study, the aerobic exercise session also 
increased circulating Irisin during (54th minute) the exercise session 
(F(3,24)=5.03, p=0.01) in healthy female adults69. Eight out of the 23 
included SGS showed that acute exercise increased circulating Iri-
sin in healthy populations12,21,22,38,58,66,70,71, while a resistance exercise 
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session increased FNDC5 mRNA in muscle only in young healthy 
adults and it did not alter circulating Irisin of both young and older 
healthy adults62. In addition, 45 minutes of running did not alter cir-
culating Irisin in obese healthy adults35. Similarly, an acute cycling 
session did not alter circulating Irisin in COPD patients34, while an 
acute exercise session did not alter FNDC5 mRNA in muscle or cir-
culating Irisin in sedentary overweight and obese adults17. Finally, 
an acute exercise session of both low and high intensity resistance 
training did not alter circulating Irisin (p>0.05) in sedentary young 
healthy females (Irisin concentrations ~69–87 ng/ml)56.
Physical activity levels were positively associated with circulat-
ing Irisin in healthy adults (r=0.20, p=0.03), but not in patients 
with diabetes type II48, and they were not associated with circu-
lating Irisin in osteoporotic women46 and in anorexic women47. 
Furthermore, circulating Irisin concentrations were higher in physi-
cally active (Irisin concentrations 128.55±78.71 ng/ml) than in 
sedentary individuals (Irisin concentrations 105.66±60.2 ng/ml) 
(p=0.006)72. However, physical activity levels were negatively 
associated with circulating Irisin (r=−0.22, p=0.001) in groups 
of anorexic, obese and healthy women36, while they were posi-
tively associated with circulating Irisin in both COPD patients 
(r=0.83, p<0.01) and healthy individuals (r=0.79, p<0.001)34. 
Finally, circulating Irisin was positively correlated with physi-
cal activity levels in individuals who demonstrated high weekly 
physical activity energy expenditure (2050–3840 kcal/week) 
(Irisin concentrations ~32–261 ng/ml, p=0.04).
Studies using mass spectrometry and western blotting
Only one included study used both western blotting and mass 
spectrometry to detect circulating Irisin in response to acute 
exercise. This study showed that submaximal acute aerobic exer-
cise increased circulating Irisin (3.1-fold over baseline, p<0.05), 
whereas maximal acute aerobic exercise did not alter circulating 
Irisin, even though tended to be significant (p=0.07), in two healthy 
volunteered adults24.
Chronic effects of exercise
Studies using ELISA
Twenty three included studies12,16,18,22,23,33,34,37,39,41,42,45,51,53–57,59,62,65,70,74 
in the current review examined the effects of chronic exercise on cir-
culating Irisin using commercial ELISA kits, while the populations 
examined showed large heterogeneity. Nine studies23,34,39,41,51,54,59,65,74 
showed that chronic exercise increased circulating Irisin, while 12 
studies12,16,18,22,33,37,42,45,53,57,62,70 showed no effects of chronic exer-
cise on circulating Irisin, and two studies showed that chronic 
exercise decreased circulating Irisin55,56, in both healthy and clinical 
populations.
A 6-month resistance training program increased circulating 
Irisin in healthy controls (p<0.01), but not in the exercisers54, 
while an 8-day vibration exercise increased circulating Irisin in 
COPD patients (p=0.01)23. Notably, the Irisin concentrations in 
the latter study23 were ~785–1196 ng/ml, a lot greater than recent 
mass spectrometry based detection of Irisin concentrations73. 
Furthermore, a 12-week resistance exercise increased circulating 
Irisin in elderly healthy females (Irisin concentrations ~61–83 
ng/ml, p<0.05,)51. In addition, a 12-week of endurance and resist-
ance combined exercise training in both healthy and pre-diabetic 
adults increased FNDC5 mRNA in muscle, while it decreased 
circulating Irisin (p<0.05) when the data of both healthy and pre- 
diabetic groups were combined16. In the latter study, Irisin con-
centrations were detected at 160 ng/ml at baseline and 143 ng/ml 
after the exercise program, a lot greater than recent mass spec-
trometry based detection of Irisin concentrations73. In addition, 
an 8-week endurance training program increased circulating 
Irisin only in middle-aged and not in young healthy adults 
(Irisin concentrations ~140–168 ng/ml, p<0.05)74, while an 8-week 
chronic exercise program in COPD patients increased circulat-
ing Irisin (p<0.05)34. Finally, a 12-month physical activity inter-
vention increased circulating Irisin by ~12% (p=0.001) in obese 
children39. Notably, in the latter study, Irisin concentrations were 
111 ng/ml, a lot greater than recent mass spectrometry based 
detection of Irisin concentrations73.
A 3-week sprint interval training program did not alter FNDC5 
mRNA in muscle and showed a gender difference in circulating 
Irisin, which was decreased in healthy males and increased in 
healthy females (p<0.05)65. An 8-week resistance exercise train-
ing program increased circulating Irisin compared to control group 
(p<0.05), while the Irisin concentrations were ~700–850 ng/ml41. 
Similarly, 3-month cross-fit training increased circulating Irisin 
(Irisin concentrations ~300–850 ng/ml, p<0.05) only in females59. 
On the other hand, a 4-week sprint exercise training decreased 
circulating Irisin (Irisin concentrations ~200-340 ng/ml, p<0.05) 
in healthy males55. Three months of both non-individualized 
training and individualized training did not alter circulating 
Irisin (Irisin concentrations ~123–131 ng/ml, p>0.05) in COPD 
patients42. Finally, an 8-week low intensity resistance training 
program did not alter circulating Irisin, while an 8-week high 
intensity resistance training program reduced circulating Irisin 
(Irisin concentrations ~51–87 ng/ml, p=0.03)56.
An 8-week resistance training program in healthy adults did not 
alter circulating Irisin33 and a 26-week aerobic exercise program 
revealed no changes in circulating Irisin of healthy adults53. A 
21-week endurance and resistance combined exercise program in 
healthy adults did not alter FNDC5 mRNA in muscle and circulat-
ing Irisin62. Similarly, a 16-week resistance exercise program in 
elderly women did not increase circulating Irisin37 and 12 weeks 
of resistance training did not alter FNDC5 mRNA in muscle or 
circulating Irisin18. However, circulating Irisin was positively cor-
related with FNDC5 mRNA in muscle (r=0.65, 95% Confidence 
Interval=0.12–0.89, p<0.05) in the latter study18. Finally, five SGS 
showed that chronic exercise did not alter circulating Irisin in healthy 
individuals12,22,57,70 and haemodialysis patients45.
Studies using mass spectrometry and western blotting
Only two included studies used alternative methods than com-
mercial ELISA kits to detect human circulating Irisin in response 
to chronic exercise. Initially, Bostrom et al. (2012) showed via 
western blotting that in eight older participants selected from 
a larger group of 27 participants67 chronic exercise increased 
FNDC5 mRNA in muscle (p<0.05) and circulating Irisin (2-fold 
over baseline, p<0.05)2. Finally, one study contrasted plasma 
Irisin concentrations in six younger individuals following 12 weeks 
high intensity aerobic exercise with those found in a separate 
group of four individuals (no pre-training samples were 
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presented)73. This study used mass spectrometry and detected 
circulating Irisin at 3.6 ng/ml in controls and 4.3 ng/ml in 
exercisers, which was significantly different between the two 
groups (p=0.04). No details regarding training or control of 
hydration in the training group were reported73.
The effects of physical activity/exercise on UCP1 in WAT
We located only one study that examined the effects of exercise on 
UCP1 mRNA in subcutaneous WAT in humans. This study found 
that a 12-week intervention of endurance and resistance combined 
exercise in both healthy and pre-diabetic adults had no significant 
effect on UCP1 mRNA in subcutaneous WAT, even though UCP1 
mRNA was increased (1.82-fold over baseline, p<0.05) when 
data from both groups were combined16. Also, UCP1 mRNA did 
not associate with FNDC5 mRNA in muscle (r=0.28, p=0.18) and 
circulating Irisin (r=-0.11, p=0.60)16.
Results for associations of Irisin with secondary outcome 
measures
The secondary results of the included studies can be found in 
Table 1. In 118 muscle profiles, FNDC5 mRNA was modestly and 
positively correlated with BMI (r2=0.1, p=0.004), while FDNC5 
mRNA was not related to fasting glucose or glycaemic control19. 
Furthermore, circulating Irisin was not associated with inflam-
matory indices39, blood glucose62,65, homeostatic model assess-
ment (HOMA)62,65,71, insulin62,65,71, leptin71, lean body mass46,57, fat 
mass18,46,57, waist to hip ratio71, energy expenditure21,54, BMI71, and 
pulmonary function34.
Additional secondary results show that circulating Irisin was 
positively associated with BMI59,70,72,75, triglycerides70,72, fat 
mass36,59, HOMA72, insulin72, blood glucose71 and leptin75, and 
negatively with high density lipoprotein cholesterol70, all of 
which indicate unfavourable effects of Irisin on human health. 
Nevertheless, some secondary evidence suggests that circulat-
ing Irisin was positively associated with fat free mass36,70, muscle 
mass41 and energy expenditure36, and Irisin that was incubated 
within white adipocytes in vitro increased glucose and fatty acids 
uptake66. Furthermore, circulating Irisin after a maximal workload 
was significantly greater in individuals with higher VO2max than 
individuals with lower VO2max21. However, circulating Irisin was 
not associated with VO2peak before and post exercise in healthy 
females57 and sedentary overweight and obese individuals, while 
it was inversely correlated with VO2peak (p<0.05) in healthy 
males60.
Discussion
The aim of the current review was to systematically identify the 
effects of physical activity on the link between PGC-1a and FNDC5 
in muscle and circulating Irisin, as well as evidence for regulation 
of UCP1 in WAT (indicating a browning process) in humans.
Overall completeness and applicability of evidence
We were unable to find strong evidence that links PGC-1α and 
FNDC5 mRNA in muscle in response to exercise training or 
increased physical activity levels. Notably, we located only one 
study that examined the effects of exercise on UCP1 in WAT, and 
this found no effect16. Despite PGC-1α being firmly placed as a 
central regulator of adaptation to exercise in mice and humans, 
numerous aspects of the literature are contradictory or incomplete. 
For example, previous evidence indicates that PGC-1α mRNA 
accumulates with endurance training, while studies of PGC-1α pro-
tein reflect various antibodies that measure distinct molecular enti-
ties ranging from 70 to >110 kDa76–78. Furthermore, mice lacking 
PGC-1α adapt normally to endurance exercise training, and in 
humans the PGC-1α regulated gene network does not correlate with 
aerobic adaptation68. Thus any argument that places Irisin as part of 
the core PGC-1α regulated exercise adaptation program needs to 
reflect, on both technical and theoretical grounds, that there is great 
uncertainty of the nature and importance of PGC-1α in exercise 
and health79.
When PGC-1α protein content is measured (albeit with uncertainty 
over protein identities) exercise training increases PGC-1α protein 
in skeletal muscle or causes nuclear translocation of protein80–83. 
However, the studies included in the current review only relied on 
measuring PGC-1α mRNA to determine the effects of exercise on 
PGC-1α, and the time-course of mRNA and protein responses to 
exercise are distinct. Thus, the link between PGC-1α and FNDC5 
in skeletal muscle may reflect measurement of mRNA dynam-
ics and this may explain inconsistent findings for PGC-1α. Also, 
the proposed mechanism by Bostrom et al. (2012) indicates that 
induction of PGC-1α mRNA and then protein would activate the 
transcription of FNDC5, and hence, if this theory was correct, it 
would be expected that a strong correlation between PGC-1α 
mRNA and FNDC5 mRNA would exist. However, previous evi-
dence showed that FNDC5 mRNA in muscle is not regularly 
increased by exercise or differently regulated between those with 
and without insulin resistance19, and was only modestly increased 
in a subset of older people following chronic exercise training19. 
If we focus on more reliable mRNA measures of PGC-1α and 
FDNC5, then the variable findings may be explained by the dif-
ferent characteristics of the populations examined and the different 
exercise protocols used.
An interesting aspect brought forward in the included studies 
showed that the start codon of the FNDC5 gene displays a varia-
tion in humans due to the non-ATG start codon64. In humans, ATG 
is usually the first codon to lead to efficient protein production, and 
therefore, the latter may suggest that Irisin, if produced, would be 
done so in an inefficient manner64. However, this notion has been 
questioned by a subsequent study, which supports that human 
Irisin is mainly translated from its non-ATG start codon, while 
the molecular weight of the protein is similar to that of important 
proteins in human body, such as insulin, leptin and resistin73, 
indicating a biological role of Irisin.
The various commercially available antibodies used in the ELISA 
kits of the studies included in the current systematic review, yield 
a protein concentration that appears to be ~5–278 times greater 
than a more recent mass spectrometry data (data that may require 
independent validation), and still far above what others have 
found84. Furthermore, Kurdiova et al. (2014) reported poor agree-
ment between ELISA kit RK-067-16 and EK-067-29 (Phoenix 
Pharmaceuticals)17. Similarly, no correlation was found between 
EK-067-52 and ELISA of Adipogen that were used in the same 
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samples26. Finally, Montes-Nieto et al. (2016) analysed human 
Irisin using two different lots (604824 and 605835) of the ELISA 
kit EK-067-29 (Phoenix Pharmaceuticals) and also found a poor 
agreement (r=0.226) between them85. These technical considera-
tions may explain part or all of the equivocal results of the included 
studies in this current review regarding circulating Irisin.
According to the results of the current systematic review, two 
studies have measured circulating Irisin via mass spectrometry 
in response to exercise in humans. In the study by Jedrychowski 
et al. (2015), blood samples for Irisin identification were collected 
only after the exercise program from a small number of partici-
pants who were sedentary (n=4) or aerobic exercisers (n=6)73. In the 
study by Lee et al. (2014), Irisin was measured only pre and post-
acute exercise without a control situation, and the sample size was 
only two participants24. Also, in the latter study a ~3-fold increase 
of Irisin was reported only after submaximal and not maximal 
exercise. These studies display methodological limitations and a 
small number of participants, which indicates that future longitudi-
nal studies of changes in Irisin will clarify if the mass spectrometry 
measures reflect exercise-induced changes. Furthermore, Bostrom 
et al. (2012) and Lee et al. (2014) used an antibody that is discon-
tinued for Irisin identification, given that it recognises a peptide of 
FNDC5 that is not part of the sequence of the secreted Irisin as this 
identified by mass spectrometry73, while Jedrychowski et al. (2015) 
used an antibody by Adipogen. This may explain the discrepancy in 
the molecular weight of Irisin between those analysed by Bostrom 
et al. (2012) and Lee et al. (2014) (~22 kDa) and those analysed 
by Jedrychowski et al. (2015) (~12 kDa). While the studies that 
utilised mass spectrometry do not agree24,73, reflecting issues of sen-
sitivity and methodology, the latest identification and analysis of 
Irisin24,73 indicates that Irisin may circulate in blood and probably 
has a similar or identical structure to the mouse structure; however, 
whether it has genuine biological activity remains to be elucidated.
Quality of evidence and limitations
Based on the studies selected for the purposes of the current review, 
we cannot reach precise conclusions regarding the effects of acute 
and chronic exercise on PGC-1α in conjunction with FNDC5 mRNA 
in muscle; this is mainly due to the inconsistency of the findings 
and the different population characteristics examined. Most of the 
RCTs33,44,49–52 display high risk of bias, due to inadequate generation 
of a randomised sequence and a lack of concealment of allocations 
before assignment, while all the RCTs exhibit high risk of bias since 
the exercise interventions could not be blinded to the participants. 
In addition, four RCTs44,49,50,52 display unclear risk of bias because 
of the lack of information regarding the blinding procedures. There-
fore, the risk of bias assessment of the included RCTs indicates that 
they may provide imprecise results (Table 2). In addition, the CTs 
and SGS display a high risk of bias due to the absence of generation 
of a randomised sequence, inadequate concealment of allocations 
before assignment and knowledge of the allocated interventions by 
the outcome assessors. They also display unclear risk of bias due to 
knowledge of the allocated interventions by the investigators during 
the study (Table 2). Finally, the included CSS display high risk of 
bias due to inadequate generation of a randomised sequence, lack 
of concealment of allocations before assignment and knowledge 
of the allocated interventions by the assessors, while they display 
unclear risk of bias for “incomplete outcome data” because of the 
lack of information of the participants who were excluded from 
the analysis. This evidence indicates that the CTs, SGS and CSS 
may also provide imprecise results. Furthermore, quality of report-
ing, as expressed through the adherence guidelines (i.e. CON-
SORT and STROBE), showed low scores of the required results 
that should have been reported (54.4% for RCTs, 58.68% for CTs, 
58.44% for SGS and 60.8% for CSS) by the included studies in the 
current review. This shows inadequate reporting of the results of 
the included studies that may not aid the critical appraisal and 
interpretation of their outcomes.
Agreements and disagreements with other studies or 
reviews
To the best of our knowledge, this is the first systematic review 
that examines the effects of physical activity on the link between 
PGC-1α and FNDC5 in muscle, circulating Irisin and on UCP1 
of WAT in humans. We compared our results with a recent meta-
analysis that aimed to identify the effects of exercise on circulat-
ing Irisin86. This meta-analysis concluded that chronic exercise may 
decrease circulating Irisin in the RCTs while the non-RCTs can-
not form any conclusion. However, the latter meta-analysis did not 
take into consideration the issues raised regarding the validity of 
the methods used for Irisin identification26. In contrast, while we 
considered the methods used for Irisin identification in the studies 
included in the current review, our review had a different aim, to 
systematically identify the effects of physical activity on the link 
between PGC-1α and FNDC5 in muscle, circulating Irisin and find 
evidence for regulation of UCP1 in WAT in humans. Regarding 
circulating Irisin, we also report that we cannot form any firm con-
clusion of the effects of exercise on circulating Irisin. Our review 
highlights previous evidence showing that circulating Irisin may 
only be detected in humans via mass spectrometry25,26,73, while we 
suggest that the previous available data coming from methods that 
have not been previously validated for circulating Irisin identifi-
cation should not be used. This is because recent evidence ques-
tioned the antibodies used in the commercial ELISA kits given 
the polyclonal nature of these antibodies that may attract cross- 
reacting proteins26. However, publications that use commercial 
ELISA that have not been previously validated to detect human 
Irisin continue at an alarming rate. Therefore, our review indicates 
to consider using only valid methods for human circulating Irisin 
identification in the future. Furthermore, our results are in accord-
ance with a previous review that showed equivocal results among 
studies examining circulating Irisin due to the methodological vari-
ations for Irisin detection87. In this critical review, the authors exam-
ined the commercial antibodies and ELISA used to measure circu-
lating Irisin and concluded that the currently available antibodies 
should be tested for cross-reacting antigens detection87. Addition-
ally, another recent review showed that the previous measurements 
for circulating Irisin identification differs greatly, given that they 
displayed a molecular weight of the protein between 0.01 ng/ml and 
2000 ng/ml88. The latter critical review concluded that it is necessary 
to establish accurate methods for irisin measurements. Our system-
atic review analysis, agrees with the latter conclusion given that the 
Irisin measurements in the included studies via commercial ELISA 
kits, displayed a molecular weight of the protein ranging between 
22 ng/ml to 1196 ng/ml.
Page 16 of 25
F1000Research 2017, 6:286 Last updated: 31 MAY 2017
Initially, Irisin was proposed to have a therapeutic effect given 
the potential to cause a browning formation of WAT that may 
have anti-obesity and antidiabetic effects2. This was mainly sug-
gested when Irisin administered in obese mice improved glucose 
homeostasis and caused weight loss2. Also, the browning 
formation that Irisin may cause could lead to reduced weight gain, 
up-regulated insulin sensitivity, reduced risk of diabetes type II 
and other metabolic disorders as animal studies indicate89–93, as 
well as increase daily resting energy expenditure in humans94,95. 
The available evidence from the included studies in the current 
review revealed that the available commercial ELISA kits for Irisin 
identification either were found to be invalid26,87 or they should be 
tested for validity87. Thus, we cannot confirm a favourable effect of 
Irisin on human metabolism. Finally, none of the included studies in 
the current review examined associations of circulating Irisin with 
indices indicate a therapeutic role of the protein using western blot-
ting and/or mass spectrometry methods.
Potential biases in the review process
The current review has a number of strengths. For instance, we 
used the PubMed and the EMBASE databases using appropri-
ate algorithms with standardized indexing terms. Standardized 
indexing terms can retrieve records that may use different words 
to describe the same concept and information beyond that may 
be contained in the words of the title and abstract96. Further-
more, the current review used a systematic manner to identify 
articles according to previous methodology27–29, and we used well- 
established tools30–32 to evaluate the included studies. To reduce 
bias, two investigators worked independently on the screening of 
the included studies for eligibility, risk of bias assessment, and in 
the provision of CONSORT and STROBE scores. Also, we have 
not excluded studies based on language. However, a limitation of 
the current review includes the use of only published literature; we 
did not include grey literature searching. In this light, there is a 
potential of publication bias in the current review. Nevertheless, 
the inclusion of grey literature may itself introduce bias and one 
reason to include grey literature would be the absence of peer-
review sources96.
Conclusions
We found little evidence to determine the link between 
PGC-1a mRNA and FNDC5 mRNA in human muscle, and there 
was limited evidence on the effects of physical activity on UCP1 
in subcutaneous WAT. We also found a heterogeneity in the popu-
lations examined, high risk of bias by the selected studies and a 
relatively small number of RCTs (n=12) with inconsistent findings 
regarding the link between physical activity, PGC-1a, FNDC5, and 
UCP1.
Mass spectrometry detection of Irisin of exercise effects were com-
promised by the methodological limitations of the existed studies 
(i.e. post exercise comparisons, lack of control, small samples). 
The current systematic review highlights previous evidence that 
indicates via mass spectrometry that Irisin is present in human 
blood at concentrations that are ~5–278 folds lower than those 
detected by commercial ELISA kits. Therefore, we are unable to 
conclude on the circulating Irisin response to physical activity due 
to methodological limitations. In this regard, our systematic review 
used well-established methodology (i.e. PRISMA and Cochrane 
Library guidelines). However, we have also considered the valid-
ity and accuracy of the measurements of Irisin protein concentra-
tions in the included studies. This additional analysis completely 
redirected our conclusion compared to the conclusion that a well- 
established systematic review methodology would provide. There-
fore, we suggest that future systematic reviews should also take into 
consideration the validity and accuracy of the measurements of the 
included studies, to avoid misleading conclusions. We also suggest 
that future studies should only consider currently valid methods 
for human circulating Irisin (i.e. mass spectrometry), until new 
methods are introduced. The latter also implies that future 
studies should re-examine the biological role for human Irisin 
and the effects of physical activity/exercise on the link between 
PGC-1a and FNDC5 in muscle, circulating Irisin and UCP1 in 
WAT.
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Germany
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Germany
The authors have addressed all of our concerns in an adequate manner. Importantly, all uncertainties
resulting from methodological problems of the irisin measurements in the included studies are now clearly
named in the re-structured discussion.
There are three minor issues left:
(I) + (II) The authors used the term “molecular weight” two times (page 16, last paragraph) when
addressing “concentrations” or “circulating levels” of irisin.
(III) Again, not the similar molecular weight of irisin compared to leptin, insulin, and resistin makes a
biological function of irisin likely but the similar circulating concentrations (discussion page 15).
 No competing interests were disclosed.Competing Interests:
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard.
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In this manuscript, the authors analyzed the effects of physical activity on the connection between muscle
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 In this manuscript, the authors analyzed the effects of physical activity on the connection between muscle
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and fibronectin type III
domain-containing protein 5 (FNDC5), circulating Irisin and uncoupling protein one (UCP1) of white
adipocytes in humans through a systematic review. The authors review the evidence connecting PGC-1α,
FNDC5, Irisin and UCP1 with physical exercise, which might play an important role in diabetes and
obesity. Moreover, they have addressed a controversial topic since, though Irisin was initially described
as a hormone potentially regulated by exercise and also with a potential role in obesity and diabetes,
conflicting results have been reported. There is an ongoing intense debate on different results from
different Irisin assays. In effect, in 2014, we were the first to underline those discrepancies and
inconsistencies. For that reason, I feel this review is timed appropriately and is interesting for the scientific
community. The review is effectively organized and the sequence of points is logical, and follows PRISMA
guideline.
In my opinion, both results and discussion are properly presented, although the discussion section should
be slightly shortened. Also, references 8 and 87 are not needed. I recommend changing PGC-1a by
PGC-1α throughout the manuscript. Furthermore, the following manuscript that was recently published
deserves to be included and discussed: Perakakis et al. (2017) .
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We thank you very much for your encouraging comments.
As per your suggestion references 8 and 87 have been removed. We have also changed PGC-1a
with PGC-1α throughout the manuscript. Finally, the reference you suggested has been included in
the discussion section along with a relevant comment (Page 37). 
 No competing interests were disclosed.Competing Interests:
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  Institute of Muscle Biology and Growth, Leibniz Institute for Farm Animal Biology, Dummerstorf,
Germany
The presented review is timely and of common interest since energy expenditure by “browning” of white
adipocytes may be a mechanism to reduce body weight and a potential way to fight obesity in humans.
Beneficial effects of exercise on metabolism are long known although not completely understood. A
recently proposed pathway linked physical activity with increased PGC1-alpha and FNDC5. Cleavage of
the transmembrane factor FNDC5 results in circulating irisin which in turn starts a sequence to induce a
brown-like phenotype in white adipocytes. Consequently, numerous studies focused on this proposed link
in different experimental settings in humans. The presented review systematically retrieved and analyzed
such studies to further elucidate different steps of the proposed cascade PGC1-alpha – FNDC5 – Irisin –
UCP1.
The value of this review bases on its rigorous quality assessment of the included studies. The authors
analyzed all published reports with established tools on the risk of bias and the quality of the data. This
part of the analysis demonstrates a rather low quality of many studies hampering the deduction of valid
conclusions. The analysis of the reported results is given in different sections considering the analyzed
parameters and the design of the studies. Results on PGC1-alpha and FNDC5 as well as on UCP1 are
presented and discussed in an appropriate manner.
In contrast, the data on irisin are much more problematic. As the authors mention in the discussion, the
missing validation of the used ELISA kits for irisin is a major issue in these studies. The values vary
greatly and, more importantly, are mostly higher by magnitudes than the values determined by mass
spectrometry. In some studies irisin was measured with different assays: Kurdiova et al. (ref. 18)
measured irisin with a RIA (RK-067-16, Phoenix) and a subset of their samples additionally with ELISA
(EK-067-29, Phoenix) and concluded “… The correlation between both assays was very weak, and
definitely not admissible for two products that claimed to measure the concentrations of the same
molecule…”. Albrecht et al. (ref. 27) re-analyzed all samples from Norheim et al. (ref. 17, EK-067-52) with
the ELISA of Adipogen and found no correlation between both measurements (r = 0.03). Finally,
Montes-Nieto et al. (2016)  analyzed irisin in human plasma with two different lots of EK-067-29 (Phoenix)
and stated an almost complete lack of agreement between the data. Latter reference should be included
in this review. These results cast doubts at least on all irisin levels determined with those kits used in more
than half of the included studies. Consequently, a meaningful discussion of the data is hardly possible.
The authors should mention these points at a prominent position and shorten the detailed discussion of
the – most likely – invalid ELISA/RIA results from the included studies.
Moreover, it should be noted that the studies using mass spectrometry delivered contradictory results.
Boström et al. (ref. 2) and Lee et al. (ref. 25) used an antibody (Abcam, now discontinued) recognizing a
peptide of FNDC5 which is not part of the secreted irisin to identify the bands subjected to mass
spectrometry whereas Jedrychowski et al. (ref. 74) employed an antibody of Adipogen against the irisin
peptide. This explains the discrepancy in the molecular weight of the analyzed peptides (~ 22 kDa [ref. 2,
25] vs. ~ 12 kDa [ref. 74]).
There is some redundancy in the description of results and repetitions in the discussion which should be
omitted. It is e.g. not necessary to repeat several times the values for irisin determined with mass
spectrometry. It would increase readability if more summarized results are presented.
 
Additionally, some minor points should be corrected:
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 Introduction
Reference 8 is not suited to support this statement because it comments the results of Boström et
al. and is no independent confirmation
Table 1, page 5
Aydin 2013: They used EK-067-52 for measurement of serum irisin. The given product H-067-17 is
an antibody for immuno-histochemistry
page 6
Moienneia 2016: The correct name of the company is CUSABIO and it is based in China – the
name and affiliation is wrong in the original publication.
 
Khodadadi 2014: They mention CUSABIO in the article. This company provides only one ELISA for
irisin therefore it is likely that they used the same test like Moienneia 2016.
page 8
Moienneia 2016: See above.
page 10
Kwasniewska 2016: Typo in the name. They used the irisin ELISA produced by the Czech
company BioVendor. The given Scottish company does not sell irisin ELISAs. This is misleadingly
described in the original article.
Discussion, page 16
Reference 87 is not suited to support the statements regarding mass spectrometry (3 times). I
guess ref. 87 (Lee DV et al.) was mixed up with ref. 25 (Lee P et al.). Please check whether ref. 87
is needed at all.
page 17
Reference 26 is not suited to support the statement regarding mass spectrometry. It was probably
mixed up with ref. 25.
 
Taken together, this systematic review is a valuable contribution to guide through the confusing literature
concerning the relationship between exercise and the proposed PGC1-alpha – FNDC5 – irisin – axis. The
evaluation of the included studies with well-acknowledged quality measures adds additional value and
makes the article unique in the reviewed field.
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We have implemented the suggested information regarding Irisin identification in content with the
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invalid ELISA (Page 37).  We would like to mention that we completely agree with the Reviewer
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 invalid ELISA (Page 37).  We would like to mention that we completely agree with the Reviewer
that a meaningful discussion regarding the effects of physical activity on Irisin is hardly possible,
given the problematic methods used for Irisin identification. In this regard, we conclude that we
cannot form any firm conclusion. Furthermore, we highlight the fact (Conclusions section) that even
though we used a well-established methodology for systematic reviews, we had to additionally
consider the validity and accuracy of the methods used in the included studies to avoid misleading
conclusions. Finally, we have mentioned all this information that was suggested by the reviewer
including the reference by Montes-Nieto et al. (2016) (Page 35).
We have implemented the information (Page 36) that the studies using mass spectrometry
delivered contradictory results.
The results section is formed based on the mechanism that this systematic review examined (i.e.
PGC-1a and FNDC5 in muscle, Irisin and UCP1 in white adipocytes) to directly reflect to the aim of
the study. In addition, we report the results considering the different kind of exercises (i.e. acute
and chronic exercise), while we separately present the relationships of the examined factors with
physical activity levels. We believe that this is particularly important to increase clarity in the
presented outcomes in line with the aim of our systematic review. However, considering your
comment, we removed the repetition from the results section (i.e. values for Irisin determined with
mass spectrometry) (Pages 31-32).  We also removed repetition from the discussion section as
per your suggestion (Pages 34).
We removed the reference 8 from the relevant statement.
We have corrected the Table 1 (Pages 9, 10, 11, 15 and 18)
Thank you for bringing to our attention that reference 87 was mixed up with reference 25. We have
now corrected this in the text.
We have removed the reference 26 that was mixed up with reference 25.
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